Treatment of hepatitis C in hemodialysis patients with pegylated interferon α-2a as monotherapy

Renal Failure

Volumn 29, Issue 8, 2007, Pages 961-966

  Sikole, Aleksandar ^a   Dzekova, Pavlina ^a   Selja, Nexhmi ^b   Gaseva, Magdalena ^c   Nikolov, Igor G ^a   Zabzun, Mustafa ^b   Muharemi, Sheriat ^b   Asani, Arben ^a   Amitov, Vili ^a   Mena, Sami ^b   Grunevska, Violeta ^c   Ivanovski, Ljubomir ^c   Polenakovic, Momir ^d  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b Institute of Nephrology   (Macedonia)

^c Clinical Centre   (Macedonia)

^d MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

Author keywords

Adverse events; Hemodialysis; Hepatitis C; Pegylated interferon 2a; Renal failure chronic

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN; PEGINTERFERON ALPHA2A; RECOMBINANT ERYTHROPOIETIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTHRALGIA; ARTICLE; BACKACHE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; FEMALE; FLU LIKE SYNDROME; GENE AMPLIFICATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HEPATITIS C; HUMAN; HYBRIDIZATION; IMMUNOTHERAPY; INJECTION SITE REACTION; INSOMNIA; MALE; MONOTHERAPY; MUSCLE WEAKNESS; MYALGIA; NEUTROPENIA; PANCYTOPENIA; PHARYNGITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RENAL DIALYSIS;

EID: 36849021715     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701641579     Document Type: Article

References (27)

1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:41-45.
2. Muir AJ, Bornstein JD, Killenberg PG: Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med. 2004;350:2265-2271.
3. Nakayama E, Akiba T, Marumo F, et al. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000;11:1896-1902.
4. Stehman-Breen CO, Emerson S, Gretch D, et al. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998;32:629-634.
5. Izopet J, Sandres-Saune K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005;77:70-76.
6. Manangan LP, Pearson ML, Tokars JI, et al. Feasibility of national surveillance of health-care-associated infections in home-care settings. Emerg Infect Dis. 2002;8:233-236.
7. Salama G, Rostaing L, Sandres K, et al. Hepatitis C virus infection in French hemodialysis units: A multicenter study. J Med Virol. 2000;61:44-51.
8. Schneeberger PM, Keur I, van der Vliet W, et al. Hepatitis C virus infections in dialysis centers in The Netherlands: A national survey by serological and molecular methods. J Clin Microbiol. 1998;36:1711-1715.
9. Tokars JI, Frank M, Alter MJ, et al. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial. 2002;15:162-171.
10. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
11. Dzekova P, Slavkovska A, Simjanovska L, et al. Prevalence of hepatitis C virus infection in dialysis patients. BANTAO Journal. 2006;4:6-7.
12. Meyers CM, Seeff LB, Stehman-Breen CO, et al. Hepatitis C and renal disease: An update. Am J Kidney Dis. 2003;42:631-657.
13. Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18:1071-1081.
14. Russo MW, Goldsweig CD, Jacobson IM, et al. Interferon monotherapy for dialysis patients with chronic hepatitis C: An analysis of the literature on efficacy and safety. Am J Gastroenterol. 2003;98:1610-1615.
15. Heathcote EJ, Shiffman ML, Cooksley WG, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med. 2000;343:1673-1680.
16. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Ann Intern Med. 2004;140:370-381.
17. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med. 2000;343:1666-1672.
18. Bruchfeld A, Lindahl K, Reichard O, et al. Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepat. 2006;13:316-321.
19. Russo MW, Ghalib R, Sigal S, et al. Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant. 2006;21:437-443.
20. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med. 1997;336:347-356.
21. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339:1485-1492.
22. Sporea I, Popescu A, Sirli R, et al. Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic hemodialysis. World J Gastroenterol. 2006; 12:4191-4194.
23. Rostaing L, Chatelut E, Payen JL, et al. Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications. J Am Soc Nephrol. 1998;9:2344-2348.
24. Pawlotsky JM. Therapy of hepatitis C: From empiricism to eradication. Hepatology. 2006;43(Suppl. 1):207-220.
25. Teta D, Luscher BL, Gonvers JJ, et al. Pegylated interferon for the treatment of hepatitis C virus in hemodialysis patients. Nephrol Dial Transplant. 2005;20:991-993.
26. Rivera M, Gentil MA, Sayago M, et al. Treatment of hepatitis C virus with interferon in hemodialysis patients awaiting kidney transplant. Transplant Proc. 2005;37:1424-1425.
27. La-Roche H. Pegasys treatment algorithm for healthcare professionals. 2006. Available at: http://www.pegasys.com/hcp/tools.aspx.